Progenics Pharmaceuticals, Inc.
Biotechnology ResearchNew York, United States11-50 Employees
Progenics is now a Lantheus company. Follow us at https://www.linkedin.com/company/lantheus-medical-imaging/
Regulatory Challenges Recent legal actions and securities fraud lawsuits against Lantheus Holdings indicate potential compliance issues and reputational risks, offering sales opportunities related to legal consulting, compliance solutions, and investor relations services.
Moderate Market Position With revenue ranging from $25M to $50M and a relatively small staff of 11-50 employees, Progenics as part of Lantheus presents opportunities for targeted business solutions that enhance operational efficiency and scale growth strategies.
Technology Adoption Utilizing advanced tools like Looker, Power BI, and Salesforce suggests openness to data analytics and customer relationship management solutions, ideal for expanding tech-driven sales enablement and process optimization offerings.
Industry Focus Operating within the biotechnology research sector with a focus on radiodiagnostics and oncology agents, there is a sales potential for specialized laboratory equipment, research tools, and clinical trial support services tailored to biotech firms.
Funding and Growth Having secured $75M in funding signifies a growth-oriented environment, which presents opportunities for financial services, strategic partnerships, and innovative product solutions to support expansion and R&D activities within the company.
Progenics Pharmaceuticals, Inc. uses 8 technology products and services including Looker, Power BI, SAP, and more. Explore Progenics Pharmaceuticals, Inc.'s tech stack below.
| Progenics Pharmaceuticals, Inc. Email Formats | Percentage |
| FLast@progenics.com | 83% |
| FiLast@progenics.com | 9% |
| FirLast@progenics.com | 4% |
| FirstLast@progenics.com | 2% |
| FL@progenics.com | 1% |
| First@progenics.com | 1% |
| First.Last@lantheus.com | 85% |
| First.L@lantheus.com | 10% |
| LastF@lantheus.com | 4% |
| Last.First@lantheus.com | 1% |
Biotechnology ResearchNew York, United States11-50 Employees
Progenics is now a Lantheus company. Follow us at https://www.linkedin.com/company/lantheus-medical-imaging/
Progenics Pharmaceuticals, Inc. has raised a total of $75M of funding over 1 rounds. Their latest funding round was raised on Aug 01, 2018 in the amount of $75M.
Progenics Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $25M$50M
Progenics Pharmaceuticals, Inc. has raised a total of $75M of funding over 1 rounds. Their latest funding round was raised on Aug 01, 2018 in the amount of $75M.
Progenics Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $25M$50M